Skip to main content

Advertisement

SpringerLink
Log in

The 5th Edition of the World Health Organization (WHO) Classification of Hematolymphoid Tumors: What’s New in Pediatrics?

  • Update
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

The World Health Organization (WHO) has revised the classification of hematolymphoid tumors (WHO-HAEM5) in August 2022 to incorporate certain recent changes in understanding of disease biology. This article highlights the important changes, with particular reference to those most relevant to children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. WHO Classification of Tumours Editorial Board. Haematolymphoid tumors. WHO Classification of Tumours series, 5th edition, volume 11 [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022 Accessed July 22, 2023. Available from: https://tumourclassification.iarc.who.int/chapters/63

    Google Scholar 

  2. International Agency for Research on Cancer. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumours, Revised 4th Edition, Volume 2 [Internet]. Accessed on July 22, 2023. Available from: https://publications.iarc.fr/Book-And-Report-Series/Who-Classfication-Of-Tumours/WHO-Classification-Of-Tumours-Of-Haematopoietic-And-Lymphoid-Tissues-2017

  3. Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720–48.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Thol F. ALL is not the same in the era of genetics. Blood. 2021;138:915–6.

    Article  CAS  PubMed  Google Scholar 

  5. Eichenauer DA, Engert A. Nodular lymphocytepredominant Hodgkin lymphoma: a unique disease deserving unique management. Hematology Am Soc Hematol Educ Program. 2017;2017:324–8.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Chabay PA, Preciado MV. EBV primary infection in childhood and its relation to B-cell lymphoma development: A mini-review from a developing region. Int J Cancer. 2013;133:1286–92.

    Article  CAS  PubMed  Google Scholar 

  7. Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization Classification of haemato lymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36:1703–19.

    Article  PubMed  PubMed Central  Google Scholar 

  8. de Vries ACH, Zwaan CM, van den Heuvel-Eibrink MM. Molecular basis of juvenile myelomonocytic leukemia. Haematologica. 2010;95:179–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Patel SS. Pediatric Myelodysplastic Syndromes. Clin Lab Med. 2021;41:517–28.

    Article  PubMed  Google Scholar 

  10. Hernández-Rivas JM. Secondary myeloid neoplasias: an emerging group of diseases. Rev Bras Hematol Hemoter. 2011;33:403–4.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Alexander TB, Gu Z, Iacobucci I, et al. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature. 2018;562:373–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Funding: None

Author information

Authors and Affiliations

  1. Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), New Delhi, India

    Debabrata Mohapatra &  Rachna Seth

  2. Department of Pathology, AIIMS, New Delhi, India

    Saumyaranjan Mallick

Authors
  1. Debabrata Mohapatra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rachna Seth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Saumyaranjan Mallick
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Contributors: DM, RS: Conceptualized the manuscript. DM, RS, SM: Wrote the manuscript. RS: Supervised the work. All authors approved the final manuscript.

Corresponding author

Correspondence to Rachna Seth.

Ethics declarations

Competing interests: None stated.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohapatra, D., Seth, R. & Mallick, S. The 5th Edition of the World Health Organization (WHO) Classification of Hematolymphoid Tumors: What’s New in Pediatrics?. Indian Pediatr 61, 69–74 (2024). https://doi.org/10.1007/s13312-024-3093-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-024-3093-4

Keywords

Search

Navigation